Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
2.440
+0.050 (2.09%)
Jun 30, 2025, 4:00 PM - Market closed
Codexis Employees
Codexis had 188 employees as of December 31, 2024. The number of employees increased by 14 or 8.05% compared to the previous year.
Employees
188
Change (1Y)
14
Growth (1Y)
8.05%
Revenue / Employee
$264,973
Profits / Employee
-$396,059
Market Cap
202.14M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CDXS News
- 5 weeks ago - Codexis' Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA - GlobeNewsWire
- 5 weeks ago - Codexis to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Codexis, Inc. (CDXS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Codexis Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting - GlobeNewsWire
- 2 months ago - Codexis to Report First Quarter 2025 Financial Results on May 14 - GlobeNewsWire
- 2 months ago - Codexis Announces Byron Dorgan to Retire from Board of Directors - GlobeNewsWire
- 4 months ago - Codexis Announces New Employment Inducement Grants - GlobeNewsWire